Renal colocalisation of Rosai-Dorfman-Destombes disease and secondary AA amyloidosis successfully treated with lenalidomide and dexamethasone.

IF 15.4 1区医学 Q1 HEMATOLOGY

Lancet Haematology Pub Date : 2024-11-01 DOI:10.1016/S2352-3026(24)00271-0

Rayane Benyahia, Charlotte Syrykh, Clotilde Gaible, Julie Belliere, Magali Colombat, Audrey Delas, Jérémie Dion, Pierre Cougoul

引用次数: 0

查看原文本刊更多论文

来那度胺和地塞米松成功治疗罗赛-多夫曼-德斯坦贝病和继发性AA淀粉样变性的肾脏共同病变。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lancet Haematology HEMATOLOGY-

CiteScore

26.00

自引率

0.80%

发文量

323

期刊介绍： Launched in autumn 2014, The Lancet Haematology is part of the Lancet specialty journals, exclusively available online. This monthly journal is committed to publishing original research that not only sheds light on haematological clinical practice but also advocates for change within the field. Aligned with the Lancet journals' tradition of high-impact research, The Lancet Haematology aspires to achieve a similar standing and reputation within its discipline. It upholds the rigorous reporting standards characteristic of all Lancet titles, ensuring a consistent commitment to quality in its contributions to the field of haematology.